The Tokyo Stock Exchange Growth Index rebounded slightly, moving in positive territory but with limited gains.

TSE Growth Market Index 813.87 +0.34 / volume 0.2 billion 39.98 million shares / trading value 121.9 billion yen TSE Growth Market 250 Index 634.38 +0.41 / volume 0.1 billion 42.47 million shares / trading value 86.4 billion yen. Today's growth market saw a slight rebound in the TSE Growth Market Index and TSE Growth Market 250 Index, with 251 rising stocks, 278 declining stocks, and 58 unchanged. Today's growth market exhibited a mixed trading scenario.

Fisco JapanNov 28 15:55

Volume change rate ranking (13:00) ~ Janome, Hosoya Fire, etc. ranked in.

In the trading volume change rate ranking, by comparing the average trading volume of the last 5 days with the trading volume on the delivery date, you can understand the interest of market participants such as trends in speculation. Top trading volume change rate [As of November 27, 13:32] (Comparison with the average trading volume of the last 5 days) Code ⇒ Stock ⇒ Volume ⇒ 5-day average volume ⇒ Volume change ratio ⇒ Stock price change rate < 3681 > V Cube 3620 3003410 0.863 35.30% 0.0438% < 2590 > DyDo 578400 12

Fisco JapanNov 27 13:04

Individual investor, Yugetsu Yugen: Paying attention to stocks that are building strong candlestick charts after the earnings season that separates the bright and dark sides of the trend. [FISCO Social Reporter]

The following is a comment written by individual investor Mr. Yugentei Tamisuke, a Fisco social reporter (blog: Profitable Stock Information "The Cat Husband's Stocks Know No Limits"). At Fisco, we strive to actively collaborate with individuals who share information in order to disseminate a wider range of information to investors. ----------- *Written on November 5, 2024 at 10:00, now that the elections in both Japan and the United States are over, we are entering the earnings season. We expect the yen to strengthen.

Fisco JapanNov 9 09:00

Modalis Therapeutics Reports Positive Foreign Exchange Gains

TipRanksNov 7 14:27

Modalis Therapeutics: Presentation of financial results for the 3rd quarter of the fiscal year ending 2024/12

JPXNov 7 14:00 · Announcements

Modalis Therapeutics: Summary of Financial Results for the 3rd Quarter Ending 2024/12 [Japanese GAAP] (Consolidated)

JPXNov 7 14:00 · Announcements